Conjugate Vaccines Market, Global Outlook and Forecast 2022-2028

April 2022 | 70 pages | ID: CFA519AE896DEN
Market Monitor Global

Abstracts

Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.

This report contains market size and forecasts of Conjugate Vaccines in global, including the following market information:

Global Conjugate Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Conjugate Vaccines Market Sales, 2017-2022, 2023-2028, (K Doses)

Global top five Conjugate Vaccines companies in 2021 (%)

The global Conjugate Vaccines market was valued at 11890 million in 2021 and is projected to reach US$ 16960 million by 2028, at a CAGR of 5.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monovalent Conjugate Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Conjugate Vaccines include Novartis, Neuron Biotech, Serum Institute of India, Pfizer, Sanofi Pasteur, Bharat Biotech, Biological, GlaxoSmithKline and Merck and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Conjugate Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Conjugate Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Conjugate Vaccines Market Segment Percentages, by Type, 2021 (%)

• Monovalent Conjugate Vaccines
• Multivalent Conjugate Vaccines

Global Conjugate Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Conjugate Vaccines Market Segment Percentages, by Application, 2021 (%)

• Children
• Adults

Global Conjugate Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Conjugate Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Conjugate Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Conjugate Vaccines revenues share in global market, 2021 (%)

Key companies Conjugate Vaccines sales in global market, 2017-2022 (Estimated), (K Doses)

Key companies Conjugate Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Neuron Biotech
• Serum Institute of India
• Pfizer
• Sanofi Pasteur
• Bharat Biotech
• Biological
• GlaxoSmithKline
• Merck
• CSL

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Conjugate Vaccines Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Conjugate Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CONJUGATE VACCINES OVERALL MARKET SIZE

2.1 Global Conjugate Vaccines Market Size: 2021 VS 2028
2.2 Global Conjugate Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Conjugate Vaccines Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Conjugate Vaccines Players in Global Market
3.2 Top Global Conjugate Vaccines Companies Ranked by Revenue
3.3 Global Conjugate Vaccines Revenue by Companies
3.4 Global Conjugate Vaccines Sales by Companies
3.5 Global Conjugate Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Conjugate Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Conjugate Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Conjugate Vaccines Players in Global Market
  3.8.1 List of Global Tier 1 Conjugate Vaccines Companies
  3.8.2 List of Global Tier 2 and Tier 3 Conjugate Vaccines Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Conjugate Vaccines Market Size Markets, 2021 & 2028
  4.1.2 Monovalent Conjugate Vaccines
  4.1.3 Multivalent Conjugate Vaccines
4.2 By Type - Global Conjugate Vaccines Revenue & Forecasts
  4.2.1 By Type - Global Conjugate Vaccines Revenue, 2017-2022
  4.2.2 By Type - Global Conjugate Vaccines Revenue, 2023-2028
  4.2.3 By Type - Global Conjugate Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Conjugate Vaccines Sales & Forecasts
  4.3.1 By Type - Global Conjugate Vaccines Sales, 2017-2022
  4.3.2 By Type - Global Conjugate Vaccines Sales, 2023-2028
  4.3.3 By Type - Global Conjugate Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Conjugate Vaccines Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Conjugate Vaccines Market Size, 2021 & 2028
  5.1.2 Children
  5.1.3 Adults
5.2 By Application - Global Conjugate Vaccines Revenue & Forecasts
  5.2.1 By Application - Global Conjugate Vaccines Revenue, 2017-2022
  5.2.2 By Application - Global Conjugate Vaccines Revenue, 2023-2028
  5.2.3 By Application - Global Conjugate Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Conjugate Vaccines Sales & Forecasts
  5.3.1 By Application - Global Conjugate Vaccines Sales, 2017-2022
  5.3.2 By Application - Global Conjugate Vaccines Sales, 2023-2028
  5.3.3 By Application - Global Conjugate Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Conjugate Vaccines Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Conjugate Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Conjugate Vaccines Revenue & Forecasts
  6.2.1 By Region - Global Conjugate Vaccines Revenue, 2017-2022
  6.2.2 By Region - Global Conjugate Vaccines Revenue, 2023-2028
  6.2.3 By Region - Global Conjugate Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Conjugate Vaccines Sales & Forecasts
  6.3.1 By Region - Global Conjugate Vaccines Sales, 2017-2022
  6.3.2 By Region - Global Conjugate Vaccines Sales, 2023-2028
  6.3.3 By Region - Global Conjugate Vaccines Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Conjugate Vaccines Revenue, 2017-2028
  6.4.2 By Country - North America Conjugate Vaccines Sales, 2017-2028
  6.4.3 US Conjugate Vaccines Market Size, 2017-2028
  6.4.4 Canada Conjugate Vaccines Market Size, 2017-2028
  6.4.5 Mexico Conjugate Vaccines Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Conjugate Vaccines Revenue, 2017-2028
  6.5.2 By Country - Europe Conjugate Vaccines Sales, 2017-2028
  6.5.3 Germany Conjugate Vaccines Market Size, 2017-2028
  6.5.4 France Conjugate Vaccines Market Size, 2017-2028
  6.5.5 U.K. Conjugate Vaccines Market Size, 2017-2028
  6.5.6 Italy Conjugate Vaccines Market Size, 2017-2028
  6.5.7 Russia Conjugate Vaccines Market Size, 2017-2028
  6.5.8 Nordic Countries Conjugate Vaccines Market Size, 2017-2028
  6.5.9 Benelux Conjugate Vaccines Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Conjugate Vaccines Revenue, 2017-2028
  6.6.2 By Region - Asia Conjugate Vaccines Sales, 2017-2028
  6.6.3 China Conjugate Vaccines Market Size, 2017-2028
  6.6.4 Japan Conjugate Vaccines Market Size, 2017-2028
  6.6.5 South Korea Conjugate Vaccines Market Size, 2017-2028
  6.6.6 Southeast Asia Conjugate Vaccines Market Size, 2017-2028
  6.6.7 India Conjugate Vaccines Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Conjugate Vaccines Revenue, 2017-2028
  6.7.2 By Country - South America Conjugate Vaccines Sales, 2017-2028
  6.7.3 Brazil Conjugate Vaccines Market Size, 2017-2028
  6.7.4 Argentina Conjugate Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Conjugate Vaccines Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Conjugate Vaccines Sales, 2017-2028
  6.8.3 Turkey Conjugate Vaccines Market Size, 2017-2028
  6.8.4 Israel Conjugate Vaccines Market Size, 2017-2028
  6.8.5 Saudi Arabia Conjugate Vaccines Market Size, 2017-2028
  6.8.6 UAE Conjugate Vaccines Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Conjugate Vaccines Major Product Offerings
  7.1.4 Novartis Conjugate Vaccines Sales and Revenue in Global (2017-2022)
  7.1.5 Novartis Key News
7.2 Neuron Biotech
  7.2.1 Neuron Biotech Corporate Summary
  7.2.2 Neuron Biotech Business Overview
  7.2.3 Neuron Biotech Conjugate Vaccines Major Product Offerings
  7.2.4 Neuron Biotech Conjugate Vaccines Sales and Revenue in Global (2017-2022)
  7.2.5 Neuron Biotech Key News
7.3 Serum Institute of India
  7.3.1 Serum Institute of India Corporate Summary
  7.3.2 Serum Institute of India Business Overview
  7.3.3 Serum Institute of India Conjugate Vaccines Major Product Offerings
  7.3.4 Serum Institute of India Conjugate Vaccines Sales and Revenue in Global (2017-2022)
  7.3.5 Serum Institute of India Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Conjugate Vaccines Major Product Offerings
  7.4.4 Pfizer Conjugate Vaccines Sales and Revenue in Global (2017-2022)
  7.4.5 Pfizer Key News
7.5 Sanofi Pasteur
  7.5.1 Sanofi Pasteur Corporate Summary
  7.5.2 Sanofi Pasteur Business Overview
  7.5.3 Sanofi Pasteur Conjugate Vaccines Major Product Offerings
  7.5.4 Sanofi Pasteur Conjugate Vaccines Sales and Revenue in Global (2017-2022)
  7.5.5 Sanofi Pasteur Key News
7.6 Bharat Biotech
  7.6.1 Bharat Biotech Corporate Summary
  7.6.2 Bharat Biotech Business Overview
  7.6.3 Bharat Biotech Conjugate Vaccines Major Product Offerings
  7.6.4 Bharat Biotech Conjugate Vaccines Sales and Revenue in Global (2017-2022)
  7.6.5 Bharat Biotech Key News
7.7 Biological
  7.7.1 Biological Corporate Summary
  7.7.2 Biological Business Overview
  7.7.3 Biological Conjugate Vaccines Major Product Offerings
  7.7.4 Biological Conjugate Vaccines Sales and Revenue in Global (2017-2022)
  7.7.5 Biological Key News
7.8 GlaxoSmithKline
  7.8.1 GlaxoSmithKline Corporate Summary
  7.8.2 GlaxoSmithKline Business Overview
  7.8.3 GlaxoSmithKline Conjugate Vaccines Major Product Offerings
  7.8.4 GlaxoSmithKline Conjugate Vaccines Sales and Revenue in Global (2017-2022)
  7.8.5 GlaxoSmithKline Key News
7.9 Merck
  7.9.1 Merck Corporate Summary
  7.9.2 Merck Business Overview
  7.9.3 Merck Conjugate Vaccines Major Product Offerings
  7.9.4 Merck Conjugate Vaccines Sales and Revenue in Global (2017-2022)
  7.9.5 Merck Key News
7.10 CSL
  7.10.1 CSL Corporate Summary
  7.10.2 CSL Business Overview
  7.10.3 CSL Conjugate Vaccines Major Product Offerings
  7.10.4 CSL Conjugate Vaccines Sales and Revenue in Global (2017-2022)
  7.10.5 CSL Key News

8 GLOBAL CONJUGATE VACCINES PRODUCTION CAPACITY, ANALYSIS

8.1 Global Conjugate Vaccines Production Capacity, 2017-2028
8.2 Conjugate Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Conjugate Vaccines Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 CONJUGATE VACCINES SUPPLY CHAIN ANALYSIS

10.1 Conjugate Vaccines Industry Value Chain
10.2 Conjugate Vaccines Upstream Market
10.3 Conjugate Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Conjugate Vaccines Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Conjugate Vaccines in Global Market
Table 2. Top Conjugate Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Conjugate Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Conjugate Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Conjugate Vaccines Sales by Companies, (K Doses), 2017-2022
Table 6. Global Conjugate Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Conjugate Vaccines Price (2017-2022) & (USD/Doses)
Table 8. Global Manufacturers Conjugate Vaccines Product Type
Table 9. List of Global Tier 1 Conjugate Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Conjugate Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Conjugate Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Conjugate Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Conjugate Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Conjugate Vaccines Sales (K Doses), 2017-2022
Table 15. By Type - Global Conjugate Vaccines Sales (K Doses), 2023-2028
Table 16. By Application – Global Conjugate Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Conjugate Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Conjugate Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Conjugate Vaccines Sales (K Doses), 2017-2022
Table 20. By Application - Global Conjugate Vaccines Sales (K Doses), 2023-2028
Table 21. By Region – Global Conjugate Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Conjugate Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Conjugate Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Conjugate Vaccines Sales (K Doses), 2017-2022
Table 25. By Region - Global Conjugate Vaccines Sales (K Doses), 2023-2028
Table 26. By Country - North America Conjugate Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Conjugate Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Conjugate Vaccines Sales, (K Doses), 2017-2022
Table 29. By Country - North America Conjugate Vaccines Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Conjugate Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Conjugate Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Conjugate Vaccines Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Conjugate Vaccines Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Conjugate Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Conjugate Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Conjugate Vaccines Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Conjugate Vaccines Sales, (K Doses), 2023-2028
Table 38. By Country - South America Conjugate Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Conjugate Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Conjugate Vaccines Sales, (K Doses), 2017-2022
Table 41. By Country - South America Conjugate Vaccines Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Conjugate Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Conjugate Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Conjugate Vaccines Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Conjugate Vaccines Sales, (K Doses), 2023-2028
Table 46. Novartis Corporate Summary
Table 47. Novartis Conjugate Vaccines Product Offerings
Table 48. Novartis Conjugate Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 49. Neuron Biotech Corporate Summary
Table 50. Neuron Biotech Conjugate Vaccines Product Offerings
Table 51. Neuron Biotech Conjugate Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 52. Serum Institute of India Corporate Summary
Table 53. Serum Institute of India Conjugate Vaccines Product Offerings
Table 54. Serum Institute of India Conjugate Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer Conjugate Vaccines Product Offerings
Table 57. Pfizer Conjugate Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 58. Sanofi Pasteur Corporate Summary
Table 59. Sanofi Pasteur Conjugate Vaccines Product Offerings
Table 60. Sanofi Pasteur Conjugate Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 61. Bharat Biotech Corporate Summary
Table 62. Bharat Biotech Conjugate Vaccines Product Offerings
Table 63. Bharat Biotech Conjugate Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 64. Biological Corporate Summary
Table 65. Biological Conjugate Vaccines Product Offerings
Table 66. Biological Conjugate Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 67. GlaxoSmithKline Corporate Summary
Table 68. GlaxoSmithKline Conjugate Vaccines Product Offerings
Table 69. GlaxoSmithKline Conjugate Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 70. Merck Corporate Summary
Table 71. Merck Conjugate Vaccines Product Offerings
Table 72. Merck Conjugate Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 73. CSL Corporate Summary
Table 74. CSL Conjugate Vaccines Product Offerings
Table 75. CSL Conjugate Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2017-2022)
Table 76. Conjugate Vaccines Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 77. Global Conjugate Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Conjugate Vaccines Production by Region, 2017-2022 (K Doses)
Table 79. Global Conjugate Vaccines Production by Region, 2023-2028 (K Doses)
Table 80. Conjugate Vaccines Market Opportunities & Trends in Global Market
Table 81. Conjugate Vaccines Market Drivers in Global Market
Table 82. Conjugate Vaccines Market Restraints in Global Market
Table 83. Conjugate Vaccines Raw Materials
Table 84. Conjugate Vaccines Raw Materials Suppliers in Global Market
Table 85. Typical Conjugate Vaccines Downstream
Table 86. Conjugate Vaccines Downstream Clients in Global Market
Table 87. Conjugate Vaccines Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Conjugate Vaccines Segment by Type
Figure 2. Conjugate Vaccines Segment by Application
Figure 3. Global Conjugate Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Conjugate Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Conjugate Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Conjugate Vaccines Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Conjugate Vaccines Revenue in 2021
Figure 9. By Type - Global Conjugate Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Conjugate Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Conjugate Vaccines Price (USD/Doses), 2017-2028
Figure 12. By Application - Global Conjugate Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Conjugate Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Conjugate Vaccines Price (USD/Doses), 2017-2028
Figure 15. By Region - Global Conjugate Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Conjugate Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Conjugate Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Conjugate Vaccines Sales Market Share, 2017-2028
Figure 19. US Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Conjugate Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Conjugate Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Conjugate Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Conjugate Vaccines Sales Market Share, 2017-2028
Figure 33. China Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Conjugate Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Conjugate Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Conjugate Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Conjugate Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Conjugate Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Conjugate Vaccines Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Conjugate Vaccines by Region, 2021 VS 2028
Figure 50. Conjugate Vaccines Industry Value Chain
Figure 51. Marketing Channels